Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by George Kassiotis and Steve Gamblin.
George Kassiotis
Connection Strength
1.222
Steve Gamblin
  1. Favorable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases. Med (N Y). 2021 Sep 10; 2(9):1093-1109.e6.
    View in: PubMed
    Score: 0.240
  2. Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains. Elife. 2021 07 29; 10.
    View in: PubMed
    Score: 0.240
  3. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science. 2020 12 11; 370(6522):1339-1343.
    View in: PubMed
    Score: 0.228
  4. Tissue-specific and interferon-inducible expression of nonfunctional ACE2 through endogenous retroelement co-option. Nat Genet. 2020 12; 52(12):1294-1302.
    View in: PubMed
    Score: 0.227
  5. AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC. Lancet. 2021 07 17; 398(10296):207-209.
    View in: PubMed
    Score: 0.060
  6. Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination. Lancet. 2021 06 19; 397(10292):2331-2333.
    View in: PubMed
    Score: 0.059
  7. Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):1000.
    View in: PubMed
    Score: 0.056
  8. Scalable and robust SARS-CoV-2 testing in an academic center. Nat Biotechnol. 2020 08; 38(8):927-931.
    View in: PubMed
    Score: 0.056
  9. Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers. Lancet. 2020 07 25; 396(10246):e6-e7.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.